Perspective: repurposed drugs for COVID-19

INTRODUCTION: The article aims to emphasize the necessity of proper research design, both scientifically and ethically, in order to provide good evidence for physicians to base their decisions on when prescribing drug treatment. METHODS: Research articles and guidelines related to therapy of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Na-Bangchang, Kesara, Porasuphatana, Supatra, Karbwang, Juntra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479713/
https://www.ncbi.nlm.nih.gov/pubmed/36160358
http://dx.doi.org/10.5114/aoms/152467
_version_ 1784790852518805504
author Na-Bangchang, Kesara
Porasuphatana, Supatra
Karbwang, Juntra
author_facet Na-Bangchang, Kesara
Porasuphatana, Supatra
Karbwang, Juntra
author_sort Na-Bangchang, Kesara
collection PubMed
description INTRODUCTION: The article aims to emphasize the necessity of proper research design, both scientifically and ethically, in order to provide good evidence for physicians to base their decisions on when prescribing drug treatment. METHODS: Research articles and guidelines related to therapy of COVID-19 were searched from the PubMed database. RESULTS: Only remdesivir and tocilizumab are medicines that have been approved by the US FDA’s decision to approve their clinical use in moderate and severe COVID-19. CONCLUSIONS: Favipiravir, ivermectin and andrographolide need further well-conducted research to confirm the efficacy and safety against COVID-19 at different stages.
format Online
Article
Text
id pubmed-9479713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-94797132022-09-22 Perspective: repurposed drugs for COVID-19 Na-Bangchang, Kesara Porasuphatana, Supatra Karbwang, Juntra Arch Med Sci Research Letter INTRODUCTION: The article aims to emphasize the necessity of proper research design, both scientifically and ethically, in order to provide good evidence for physicians to base their decisions on when prescribing drug treatment. METHODS: Research articles and guidelines related to therapy of COVID-19 were searched from the PubMed database. RESULTS: Only remdesivir and tocilizumab are medicines that have been approved by the US FDA’s decision to approve their clinical use in moderate and severe COVID-19. CONCLUSIONS: Favipiravir, ivermectin and andrographolide need further well-conducted research to confirm the efficacy and safety against COVID-19 at different stages. Termedia Publishing House 2022-08-30 /pmc/articles/PMC9479713/ /pubmed/36160358 http://dx.doi.org/10.5114/aoms/152467 Text en Copyright: © 2022 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Research Letter
Na-Bangchang, Kesara
Porasuphatana, Supatra
Karbwang, Juntra
Perspective: repurposed drugs for COVID-19
title Perspective: repurposed drugs for COVID-19
title_full Perspective: repurposed drugs for COVID-19
title_fullStr Perspective: repurposed drugs for COVID-19
title_full_unstemmed Perspective: repurposed drugs for COVID-19
title_short Perspective: repurposed drugs for COVID-19
title_sort perspective: repurposed drugs for covid-19
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479713/
https://www.ncbi.nlm.nih.gov/pubmed/36160358
http://dx.doi.org/10.5114/aoms/152467
work_keys_str_mv AT nabangchangkesara perspectiverepurposeddrugsforcovid19
AT porasuphatanasupatra perspectiverepurposeddrugsforcovid19
AT karbwangjuntra perspectiverepurposeddrugsforcovid19

Ejemplares similares